Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and...
Change of Director's Interest Notice
Filed with ASX · · 2 pages · English
Release
Percheron Therapeutics Limited on 6ix
Earlier from Percheron Therapeutics
- Notice under S708A
- Application for quotation of securities - PER
- Notification regarding unquoted securities - PER
- Results of Annual General Meeting
- Annual General Meeting - Management Presentation
Later from Percheron Therapeutics
- PER: Percheron and Invion Explore Cancer Combination Therapy
- Photosoft & Novel Immunotherapy Collab Partnership
- Quarterly Activities Report and Appendix 4C
- Completion of HMBD-002 Drug Product Manufacture
- Listing Rule waiver to allow quotation of PERAQ options
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics